Applied Therapeutics Inc (APLT)
Cours de l'action
Résultats financiers
Value bought
90 derniers jours
Value sold
90 derniers jours
Net insiders buying
90 derniers jours
Trades (buy and sell)
90 derniers jours
Rechercher
| Date de notification | Date de transaction | A/V Type de transaction | Initié et/ou titre |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur | Détails |
|---|---|---|---|---|---|---|---|---|
| 2025-03-06 | 2025-03-04 | V Vente |
Chief Medical Officer Dirigeant |
10 366
-1.2%
0,444 561 USD |
10 366 -1.2% | 0,44 | 4 561 USD | |
| 2025-03-06 | 2025-03-04 | V Vente |
See Remarks Dirigeant |
447
-0.2%
0,44197 USD |
447 -0.2% | 0,44 | 197 USD | |
| 2025-03-06 | 2025-03-04 | V Vente |
See Remarks Administrateur exécutif |
14 502
-3.6%
0,446 381 USD |
14 502 -3.6% | 0,44 | 6 381 USD | |
| 2025-02-07 | 2025-02-06 | V Vente |
Chief Medical Officer Dirigeant |
86 078
-8.7%
0,6152 508 USD |
86 078 -8.7% | 0,61 | 52 508 USD | |
| 2025-02-07 | 2025-02-06 | V Vente |
See Remarks Dirigeant |
28 117
-9.4%
0,6117 151 USD |
28 117 -9.4% | 0,61 | 17 151 USD | |
| 2025-02-07 | 2025-02-06 | V Vente |
See Remarks Administrateur exécutif |
22 950
-5.4%
0,6114 000 USD |
22 950 -5.4% | 0,61 | 14 000 USD | |
| 2024-08-23 | 2024-08-22 | V Vente |
Chief Medical Officer Dirigeant |
22 681
-2.2%
5,83132 230 USD |
22 681 -2.2% | 5,83 | 132 230 USD | |
| 2024-08-23 | 2024-08-22 | V Vente |
Chief Financial Officer Administrateur exécutif |
13 530
-4.6%
5,8378 880 USD |
13 530 -4.6% | 5,83 | 78 880 USD | |
| 2024-08-14 | 2024-08-14 | V Vente |
President and CEO Administrateur exécutif |
119 591
-2.5%
5,93709 175 USD |
119 591 -2.5% | 5,93 | 709 175 USD | |
| 2024-08-14 | 2024-08-13 | V Vente |
President and CEO Administrateur exécutif |
357 423
-6.9%
6,182 208 874 USD |
357 423 -6.9% | 6,18 | 2 208 874 USD | |
| 2024-08-14 | 2024-08-12 | V Vente |
President and CEO Administrateur exécutif |
300 000
-5.5%
5,981 794 000 USD |
300 000 -5.5% | 5,98 | 1 794 000 USD | |
| 2024-06-10 | 2024-06-06 | V Vente |
President and CEO Administrateur exécutif Actionnaire important |
61 795
-1.6%
4,32266 954 USD |
61 795 -1.6% | 4,32 | 266 954 USD | |
| 2024-06-10 | 2024-06-06 | V Vente |
Chief Financial Officer Administrateur exécutif |
16 980
-5.5%
4,3273 354 USD |
16 980 -5.5% | 4,32 | 73 354 USD | |
| 2024-06-10 | 2024-06-06 | V Vente |
Chief Medical Officer Dirigeant |
22 003
-2.1%
4,3295 053 USD |
22 003 -2.1% | 4,32 | 95 053 USD | |
| 2024-06-06 | 2024-06-05 | V Vente |
ALEXANDRIA REAL ESTATE EQUITIES, INC. Actionnaire important |
150 000
-2.5%
4,24636 000 USD |
150 000 -2.5% | 4,24 | 636 000 USD | |
| 2024-06-06 | 2024-06-04 | V Vente |
ALEXANDRIA REAL ESTATE EQUITIES, INC. Actionnaire important |
150 000
-2.4%
4,21631 500 USD |
150 000 -2.4% | 4,21 | 631 500 USD | |
| 2024-03-18 | 2024-03-14 | V Vente |
Chief Commercial Officer Dirigeant |
48 871
-6.3%
5,39263 415 USD |
48 871 -6.3% | 5,39 | 263 415 USD | |
| 2024-03-18 | 2024-03-14 | V Vente |
Chief Medical Officer Dirigeant |
110 804
-9.7%
5,39597 234 USD |
110 804 -9.7% | 5,39 | 597 234 USD | |
| 2024-03-18 | 2024-03-14 | V Vente |
Chief Financial Officer Administrateur exécutif |
28 727
-8.5%
5,39154 839 USD |
28 727 -8.5% | 5,39 | 154 839 USD | |
| 2024-03-18 | 2024-03-14 | V Vente |
President and CEO Administrateur exécutif Actionnaire important |
318 573
-7.7%
5,391 717 108 USD |
318 573 -7.7% | 5,39 | 1 717 108 USD | |
| 2023-12-05 | 2023-12-01 | A Achat | Administrateur non-exécutif |
30 000
+90.9%
2,1865 367 USD |
30 000 +90.9% | 2,18 | 65 367 USD | |
| 2023-12-01 | 2023-11-30 | V Vente |
President and CEO Administrateur exécutif Actionnaire important |
3 968
-0.2%
1,977 817 USD |
3 968 -0.2% | 1,97 | 7 817 USD | |
| 2023-12-01 | 2023-11-30 | V Vente |
Chief Commercial Officer Dirigeant |
965
-0.3%
1,971 901 USD |
965 -0.3% | 1,97 | 1 901 USD | |
| 2023-12-01 | 2023-11-30 | V Vente |
Chief Medical Officer Dirigeant |
1 583
-0.2%
1,973 119 USD |
1 583 -0.2% | 1,97 | 3 119 USD | |
| 2023-11-06 | 2023-11-03 | V Vente |
ALEXANDRIA REAL ESTATE EQUITIES, INC. Actionnaire important |
143 450
-2.5%
2,31331 370 USD |
143 450 -2.5% | 2,31 | 331 370 USD | |
| 2023-11-06 | 2023-11-02 | V Vente |
ALEXANDRIA REAL ESTATE EQUITIES, INC. Actionnaire important |
103 808
-1.8%
2,32240 835 USD |
103 808 -1.8% | 2,32 | 240 835 USD | |
| 2023-11-02 | 2023-11-01 | V Vente |
ALEXANDRIA REAL ESTATE EQUITIES, INC. Actionnaire important |
172 742
-2.9%
2,36407 671 USD |
172 742 -2.9% | 2,36 | 407 671 USD | |
| 2023-11-02 | 2023-10-31 | V Vente |
ALEXANDRIA REAL ESTATE EQUITIES, INC. Actionnaire important |
155 000
-2.5%
2,41373 550 USD |
155 000 -2.5% | 2,41 | 373 550 USD | |
| 2023-09-29 | 2023-09-27 | V Vente |
Chief Commercial Officer Dirigeant |
9 720
-2.5%
2,7026 244 USD |
9 720 -2.5% | 2,70 | 26 244 USD | |
| 2023-09-29 | 2023-09-27 | V Vente |
Chief Medical Officer Dirigeant |
10 932
-1.6%
2,7029 516 USD |
10 932 -1.6% | 2,70 | 29 516 USD | |
| 2023-09-29 | 2023-09-27 | V Vente |
President and CEO Administrateur exécutif Actionnaire important |
115 632
-4.3%
2,70312 206 USD |
115 632 -4.3% | 2,70 | 312 206 USD | |
| 2023-01-13 | 2023-01-11 | V Vente |
President and CEO Administrateur exécutif Actionnaire important |
15 870
-2.1%
0,9114 442 USD |
15 870 -2.1% | 0,91 | 14 442 USD | |
| 2023-01-13 | 2023-01-11 | V Vente |
Chief Medical Officer Dirigeant |
6 053
-3.8%
0,915 508 USD |
6 053 -3.8% | 0,91 | 5 508 USD | |
| 2023-01-13 | 2023-01-11 | V Vente |
Chief Commercial Officer Dirigeant |
4 495
-4.6%
0,914 090 USD |
4 495 -4.6% | 0,91 | 4 090 USD | |
| 2022-10-14 | 2022-10-14 | A Achat |
President and CEO Administrateur exécutif Actionnaire important |
50 000
+7.0%
0,6532 250 USD |
50 000 +7.0% | 0,65 | 32 250 USD | |
| 2022-10-13 | 2022-10-13 | A Achat |
President and CEO Administrateur exécutif Actionnaire important |
73 256
+11.4%
0,5640 891 USD |
73 256 +11.4% | 0,56 | 40 891 USD | |
| 2022-10-12 | 2022-10-12 | A Achat |
President and CEO Administrateur exécutif Actionnaire important |
38 153
+6.3%
0,5219 943 USD |
38 153 +6.3% | 0,52 | 19 943 USD | |
| 2022-06-29 | 2022-06-27 | A Achat |
ALEXANDRIA REAL ESTATE EQUITIES, INC. Actionnaire important |
2 065 000
+82.9%
1,002 065 000 USD |
2 065 000 +82.9% | 1,00 | 2 065 000 USD | |
| 2022-06-29 | 2022-06-27 | A Achat |
ALEXANDRIA REAL ESTATE EQUITIES, INC. Actionnaire important |
1 435 000
+152.0%
1,001 435 000 USD |
1 435 000 +152.0% | 1,00 | 1 435 000 USD | |
| 2022-05-18 | 2022-05-16 | V Vente |
See Remarks Dirigeant |
905
-8.5%
1,651 493 USD |
905 -8.5% | 1,65 | 1 493 USD | |
| 2022-03-23 | 2022-03-23 | A Achat |
Chief Medical Officer Dirigeant |
30 000
+22.9%
1,9759 100 USD |
30 000 +22.9% | 1,97 | 59 100 USD | |
| 2022-03-23 | 2022-03-22 | A Achat |
Chief Medical Officer Dirigeant |
21 961
+20.2%
1,9843 483 USD |
21 961 +20.2% | 1,98 | 43 483 USD | |
| 2022-03-23 | 2022-03-21 | A Achat |
Chief Medical Officer Dirigeant |
12 548
+13.0%
1,8523 214 USD |
12 548 +13.0% | 1,85 | 23 214 USD | |
| 2021-09-14 | 2021-09-14 | A Achat |
President and CEO Administrateur exécutif Actionnaire important |
9 300
+2.6%
14,49134 740 USD |
9 300 +2.6% | 14,49 | 134 740 USD | |
| 2021-09-14 | 2021-09-13 | A Achat |
President and CEO Administrateur exécutif Actionnaire important |
701
+0.2%
14,6910 298 USD |
701 +0.2% | 14,69 | 10 298 USD | |
| 2021-06-10 | 2021-06-08 | V Vente |
Chief Financial Officer Dirigeant |
5 047
-5.4%
21,42108 107 USD |
5 047 -5.4% | 21,42 | 108 107 USD | |
| 2021-06-07 | 2021-06-07 | VP Vente planifiée |
Chief Medical Officer Dirigeant |
260
-100.0%
21,385 559 USD |
260 -100.0% | 21,38 | 5 559 USD | |
| 2021-06-07 | 2021-06-07 | VP Vente planifiée |
Chief Medical Officer Dirigeant |
200
-43.5%
20,434 086 USD |
200 -43.5% | 20,43 | 4 086 USD | |
| 2021-06-07 | 2021-06-04 | VP Vente planifiée |
Chief Medical Officer Dirigeant |
460
-100.0%
19,659 039 USD |
460 -100.0% | 19,65 | 9 039 USD | |
| 2021-06-07 | 2021-06-03 | VP Vente planifiée |
Chief Medical Officer Dirigeant |
460
-100.0%
19,669 044 USD |
460 -100.0% | 19,66 | 9 044 USD | |
| 2021-05-28 | 2021-05-26 | V Vente |
Chief Commercial Officer Dirigeant |
2 894
-7.9%
18,3553 105 USD |
2 894 -7.9% | 18,35 | 53 105 USD | |
| 2021-04-30 | 2021-04-30 | VP Vente planifiée |
Chief Medical Officer Dirigeant |
460
-100.0%
18,328 427 USD |
460 -100.0% | 18,32 | 8 427 USD | |
| 2021-04-30 | 2021-04-29 | VP Vente planifiée |
Chief Medical Officer Dirigeant |
460
-100.0%
18,288 409 USD |
460 -100.0% | 18,28 | 8 409 USD | |
| 2021-04-30 | 2021-04-28 | VP Vente planifiée |
Chief Medical Officer Dirigeant |
300
-100.0%
18,925 676 USD |
300 -100.0% | 18,92 | 5 676 USD | |
| 2021-04-30 | 2021-04-28 | VP Vente planifiée |
Chief Medical Officer Dirigeant |
1 340
-81.7%
18,3324 562 USD |
1 340 -81.7% | 18,33 | 24 562 USD | |
| 2021-03-30 | 2021-03-30 | VP Vente planifiée |
Chief Medical Officer Dirigeant |
460
-100.0%
18,438 478 USD |
460 -100.0% | 18,43 | 8 478 USD | |
| 2021-03-30 | 2021-03-29 | VP Vente planifiée |
Chief Medical Officer Dirigeant |
465
-100.0%
18,538 616 USD |
465 -100.0% | 18,53 | 8 616 USD | |
| 2021-03-30 | 2021-03-26 | VP Vente planifiée |
Chief Medical Officer Dirigeant |
465
-100.0%
19,689 151 USD |
465 -100.0% | 19,68 | 9 151 USD | |
| 2021-03-15 | 2021-03-15 | VP Vente planifiée |
Chief Medical Officer Dirigeant |
465
-100.0%
19,619 119 USD |
465 -100.0% | 19,61 | 9 119 USD | |
| 2021-03-15 | 2021-03-12 | VP Vente planifiée |
Chief Medical Officer Dirigeant |
465
-100.0%
19,389 012 USD |
465 -100.0% | 19,38 | 9 012 USD | |
| 2021-03-15 | 2021-03-11 | VP Vente planifiée |
Chief Medical Officer Dirigeant |
465
-100.0%
18,488 593 USD |
465 -100.0% | 18,48 | 8 593 USD | |
| 2021-02-25 | 2021-02-25 | VP Vente planifiée |
Chief Medical Officer Dirigeant |
1 295
-100.0%
23,2030 044 USD |
1 295 -100.0% | 23,20 | 30 044 USD | |
| 2021-02-25 | 2021-02-24 | VP Vente planifiée |
Chief Medical Officer Dirigeant |
600
-100.0%
24,5714 742 USD |
600 -100.0% | 24,57 | 14 742 USD | |
| 2021-02-25 | 2021-02-24 | VP Vente planifiée |
Chief Medical Officer Dirigeant |
1 525
-71.8%
23,7136 158 USD |
1 525 -71.8% | 23,71 | 36 158 USD | |
| 2021-02-25 | 2021-02-23 | VP Vente planifiée |
Chief Medical Officer Dirigeant |
465
-100.0%
21,8410 156 USD |
465 -100.0% | 21,84 | 10 156 USD | |
| 2021-02-24 | 2021-02-19 | A Achat | Administrateur non-exécutif |
6 500
+100.0%
22,86148 590 USD |
6 500 +100.0% | 22,86 | 148 590 USD | |
| 2021-02-19 | 2021-02-17 | A Achat |
ALEXANDRIA REAL ESTATE EQUITIES, INC. Actionnaire important |
43 478
+3.5%
23,00999 994 USD |
43 478 +3.5% | 23,00 | 999 994 USD | |
| 2021-02-03 | 2021-02-03 | VP Vente planifiée |
Chief Medical Officer Dirigeant |
600
-100.0%
27,3016 380 USD |
600 -100.0% | 27,30 | 16 380 USD | |
| 2021-02-03 | 2021-02-03 | VP Vente planifiée |
Chief Medical Officer Dirigeant |
695
-53.7%
26,3518 313 USD |
695 -53.7% | 26,35 | 18 313 USD | |
| 2021-02-03 | 2021-02-02 | VP Vente planifiée |
Chief Medical Officer Dirigeant |
595
-100.0%
27,7716 523 USD |
595 -100.0% | 27,77 | 16 523 USD | |
| 2021-02-03 | 2021-02-02 | VP Vente planifiée |
Chief Medical Officer Dirigeant |
700
-54.1%
26,8718 809 USD |
700 -54.1% | 26,87 | 18 809 USD | |
| 2021-02-03 | 2021-02-01 | VP Vente planifiée |
Chief Medical Officer Dirigeant |
660
-100.0%
26,4317 444 USD |
660 -100.0% | 26,43 | 17 444 USD | |
| 2021-02-03 | 2021-02-01 | VP Vente planifiée |
Chief Medical Officer Dirigeant |
800
-21.1%
24,3619 488 USD |
800 -21.1% | 24,36 | 19 488 USD | |
| 2021-01-21 | 2021-01-21 | VP Vente planifiée |
Chief Medical Officer Dirigeant |
465
-100.0%
20,309 440 USD |
465 -100.0% | 20,30 | 9 440 USD | |
| 2021-01-21 | 2021-01-20 | VP Vente planifiée |
Chief Medical Officer Dirigeant |
465
-100.0%
21,089 802 USD |
465 -100.0% | 21,08 | 9 802 USD |